Two Existing Drugs Identified as Potential Therapy for LAM Lung Disease
A treatment for the rare cancer-like lung disease found in women of childbearing age may have been discovered by University of Cincinnati researchers.
Tag: LAM Lymphangioleiomyomatosis
Two Existing Drugs Identified as Potential Therapy for LAM Lung Disease
A treatment for the rare cancer-like lung disease found in women of childbearing age may have been discovered by University of Cincinnati researchers.
Read More
New Features of LAM Lung Disease Discovered
Lymphangioleiomyomatosis (LAM) is rare lung disease that commonly features the growth of abnormal cells in different tissues and organs and affects about 1 in 200,000 Americans.
Read More
New Guidelines Issued for Diagnosis and Care of LAM Lung Disease
Additional clinical practice guidelines have been published regarding the diagnosis of lymphangioleiomyomatosis (LAM) and management of pneumothoraces in LAM patients.
Read MoreFDA Approves First Drug to Treat Rare Lung Disease LAM
The US FDA has approved Rapamune (sirolimus) to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of childbearing age.
Read More